Governance Acurx Pharmaceuticals, Inc.

ACXP

US00510M2035

Biotechnology & Medical Research

Delayed Nasdaq Other stock markets 00:07:17 12/06/2026 HKT			5-day change	1st Jan Change
1.580 ^USD	-1.25%		-10.73%	-36.55%

05-20	Acurx Pharmaceuticals Highlights FDA's Guidance That Could Accelerate Approval Path for Ibezapolstat	CI
05-12	Acurx Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 12, 2026

Executive Committee: Acurx Pharmaceuticals, Inc.

Manager

Positions heldSince

David Luci

59 year

Chief Executive Officer	01/07/2017
Founder	01/07/2017
Public Communications Contact	01/07/2017
President	01/07/2017
Corporate Secretary	01/07/2017

Robert Shawah

59 year

Director of Finance/CFO	01/07/2017
Founder	01/07/2017

Michael Silverman

Chief Tech/Sci/R&D Officer

Lisa Wilson

Investor Relations Contact

Mintz Levin

General Counsel

Composition of the Board of Directors: Acurx Pharmaceuticals, Inc.

Director

CommitteesSince

Robert de Luccia

80 year

Audit Committee	25/05/2010
Compensation Committee	21/01/2010
Governance Committee Chair

Thomas Harrison

78 year

Audit Committee	24/06/2021
Compensation Committee Chair	01/07/2020
Compensation Committee	24/06/2021
Audit Committee Chair	05/11/2024
Finance Committee Chair	05/11/2024
Governance Committee Chair	05/11/2024
Nominating Committee Chair	05/11/2024

Joseph Scodari

73 year

Audit Committee	24/06/2021
Compensation Committee Chair	24/06/2021

James Donohue

56 year

Audit Committee Chair

24/06/2021

Jack Dean

84 year

Finance Committee

14/02/2014

Carl Sailer

56 year

Compensation Committee

23/10/2018

David Luci

59 year

Director/Board Member

01/07/2017

Latest Appointments: Acurx Pharmaceuticals, Inc.

08/08/24

Agenus Inc. Appoints Tom Harrison to Its Board of Directors

More news

Former Officers and Directors: Acurx Pharmaceuticals, Inc.

Insider

Positions held

SinceUntil

Paul Baehr

Director/Board Member

Mark Rathjen

Director/Board Member

Michael E. Duffy

Director/Board Member

John Terrana

Director/Board Member

Katie Jadhon

Director/Board Member

John Anthony Jadhon

Director/Board Member

Age distribution of managers

Parity Men Women

Male	13
Female	1

Of which Executive Committee

Male	4
Female	1

Of which Directors

Male	7
Female	0

Acurx Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. It develops antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its research and development (R&D) pipeline include antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile (C. difficile), methicillin-resistant Staphylococcus aureus (MRSA), vancomycin resistant Enterococcus (VRE), drug-resistant Streptococcus pneumoniae (DRSP) and B. anthracis (anthrax; a Bioterrorism Category A Threat-Level pathogen). Its lead antibiotic candidate, ibezapolstat targets the pol IIIC enzyme.

Employees

Sector

Biotechnology & Medical Research

More about the company